ArticleCancer science2020

Lorlatinib in previously treated anaplastic lymphoma kinase-rearranged non-small cell lung cancer: Japanese subgroup analysis of a global study.

Takashi Seto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.